Article
TK216 targets microtubules in Ewing sarcoma cells
2021-11-19
Abstract excerpt
<h4>ABSTRACT</h4> Ewing sarcoma (EWS) is a pediatric malignancy driven by the EWSR1-FLI1 fusion protein formed by the chromosomal translocation t(11;22). The small molecule TK216 was developed as a first-in-class direct EWSR1-FLI1 inhibitor and is in phase II clinical trials in combination with vincristine for EWS patients. However, TK216 exhibits anti-cancer activity against cancer cell lines and xenografts that...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22ff73e5-07ec-53e7-a958-5e9bc270aa6b
- DOI
- 10.1101/2021.11.19.469182
